Trifluoperazine, an Antipsychotic Agent, Inhibits Cancer Stem Cell Growth and Overcomes Drug Resistance of Lung Cancer.
CONCLUSIONS: Using in silico drug screening via Connectivity Map followed by empirical validations, we repurposed an existing phenothiazine-like anti-psychotic drug, trifluoperazine, as a potential anti-CSC agent that could overcome EGFR-TKI and chemotherapy resistance.
PMID: 23024022 [PubMed - as supplied by publisher] (Source: American Journal of Respiratory and Critical Care Medicine)